Sionna Therapeutics, Inc.
SION
$35.31
-$0.76-2.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.88% | 54.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.43% | 8.42% | |||
| Operating Income | -11.43% | -8.42% | |||
| Income Before Tax | -9.62% | -4.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.62% | -4.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.62% | -4.00% | |||
| EBIT | -11.43% | -8.42% | |||
| EBITDA | -11.58% | -8.54% | |||
| EPS Basic | 33.92% | 81.66% | |||
| Normalized Basic EPS | 33.90% | 81.66% | |||
| EPS Diluted | 33.92% | 81.66% | |||
| Normalized Diluted EPS | 33.90% | 81.66% | |||
| Average Basic Shares Outstanding | 65.88% | 466.95% | |||
| Average Diluted Shares Outstanding | 65.88% | 466.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||